Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.47 | 4e-16 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.44 | 2e-13 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-09 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-08 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-08 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-08 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-07 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-07 |